Dr. Ajay Kumar is a consultant physician and diabetologist currently practising in Patna, India. He is a highly skilled and specialized diabetologist, and the principal investigator for phase III trials of antidiabetic drugs like GLP1 receptors, SGLT2 inhibitors, and DPP4 inhibitors.
In this exclusive commentary, Dr. Ajay Kumar shares insights on the challenges faced with insulin treatment in patients with type-2 diabetes mellitus .
China Reports First Commercial Brain-Computer Interface Implant for Spinal Cord Injury
Anatomy & Physiology
1h ago
0
Rare Triple Procedure Addresses Breast Cancer and Silent Cardiac Disease in One Operation
Cardiology
1h ago
0
India Adds Nearly 10,000 MBBS Seats for 2026 to 2027 Academic Session
Allergy & Immunology
8h ago
112
Which Therapy Directly Targets the Pituitary in Cushing Disease?
Endocrinology
8h ago
155
Retina Clinic Visits Reveal Widespread Uncontrolled BP in Diabetes
Cardiology
11h ago
218
2
Andhra Pradesh Reports 12 COVID-19 Infections and Four Deaths Between June 26 and July 16
Anesthesiology
13h ago
173
1